Length of Stay Among Infants with Neonatal Abstinence Syndrome and Risk of Hospital Readmission

被引:2
|
作者
Diop, Hafsatou [1 ]
Cui, Xiaohui [1 ]
Nielsen, Timothy [1 ]
Peacock-Chambers, Elizabeth [2 ]
Gupta, Munish [3 ]
机构
[1] Massachusetts Dept Publ Hlth, 250 Washington St,6th Floor, Boston, MA 02108 USA
[2] Univ Massachusetts, Sch Med Baystate, Springfield, MA USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
Neonatal abstinence syndrome (NAS); Length of stay; Readmissions; PELL; UNITED-STATES; OPIOID USE; BIRTH; CARE;
D O I
10.1007/s10995-022-03481-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives To assess whether a shorter length of stay (LOS) is associated with a higher risk of readmission among newborns with neonatal abstinence syndrome (NAS) and examine the risk, causes, and characteristics associated with readmissions among newborns with NAS, using a longitudinally linked population-based database. Methods Our study sample included full-term singletons with NAS (n = 4,547) and without NAS (n = 327,836), born in Massachusetts during 2011-2017. We used log-binomial regression models to estimate the crude risk ratios (cRRs) and adjusted RRs with 95% confidence intervals (CI) of the association between LOS and readmissions, controlling for maternal age, race/ethnicity, education, marital status, insurance, method of delivery, birthweight, adequacy of prenatal care, smoking, and abnormal conditions of newborn. Results Compared with infants without NAS, infants with NAS had a non-significantly higher risk of readmission within 2-42 days (2.8% vs. 2.5%; p = 0.17) and a significantly higher risk of readmission within 43-182 days (2.7% vs. 1.8%; p < 0.001). The risk of readmission within 2-42 days was significantly higher among infants with NAS with a LOS of 0-6 days compared to a LOS of 14-20 days (reference group) (aRR: 2.1; 95% CI: 1.2-3.5). No significant differences in readmission rates between 43 and 182 days were observed across LOS categories. Conclusions Among infants with NAS, a LOS of 0-6 days was associated with a significantly higher risk of readmission within 2-42 days of discharge compared to a longer LOS.
引用
收藏
页码:2020 / 2029
页数:10
相关论文
共 50 条
  • [1] Length of Stay Among Infants with Neonatal Abstinence Syndrome and Risk of Hospital Readmission
    Hafsatou Diop
    Xiaohui Cui
    Timothy Nielsen
    Elizabeth Peacock-Chambers
    Munish Gupta
    [J]. Maternal and Child Health Journal, 2022, 26 : 2020 - 2029
  • [2] Factors Impacting Length of Treatment and Length of Hospital Stay in Neonatal Abstinence Syndrome
    Stoff, Elsa
    Hunter, Krystal
    Kushnir, Alla
    [J]. PEDIATRICS, 2021, 147 (03)
  • [3] Length of hospital stay (LOS) of infants treated with oral morphine preparations for neonatal abstinence syndrome (NAS)
    Lainwala, S
    Brown, E
    Weinschenk, N
    Blackwell, M
    Hagadorn, J
    [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 487A - 488A
  • [4] The Effect of Breast Milk Feeding on Length of Hospital Stay and Requirement of Treatment in Infants Diagnosed with Neonatal Abstinence Syndrome
    Aboaziza, Ahmad
    Gibson, Jennifer
    Bharti, Des
    Shah, Darshan
    Ahmed, Husan
    Chen, Yang
    Sayam, Sonica
    Kozinetz, Claudia
    [J]. PEDIATRICS, 2018, 141
  • [5] The Association Between Breastfeeding and Length of Hospital Stay Among Infants Diagnosed with Neonatal Abstinence Syndrome: A Population-Based Study of In-Hospital Births
    Short, Vanessa L.
    Gannon, Meghan
    Abatemarco, Diane J.
    [J]. BREASTFEEDING MEDICINE, 2016, 11 (07) : 343 - 349
  • [6] Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome
    V N Tolia
    K Murthy
    M M Bennett
    E S Miller
    D K Benjamin
    P B Smith
    R H Clark
    [J]. Journal of Perinatology, 2018, 38 : 75 - 79
  • [7] Decreasing Total Medication Exposure and Length of Stay While Completing Withdrawal for Neonatal Abstinence Syndrome during the Neonatal Hospital Stay
    Devlin, Lori A.
    Lau, Timothy
    Radmacher, Paula G.
    [J]. FRONTIERS IN PEDIATRICS, 2017, 5
  • [8] Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome
    Tolia, V. N.
    Murthy, K.
    Bennett, M. M.
    Miller, E. S.
    Benjamin, D. K.
    Smith, P. B.
    Clark, R. H.
    [J]. JOURNAL OF PERINATOLOGY, 2018, 38 (01) : 75 - 79
  • [9] DECREASING TOTAL DRUG EXPOSURE AND LENGTH OF STAY WHILE COMPLETING WITHDRAWAL FOR NEONATAL ABSTINENCE SYNDROME DURING THE NEONATAL HOSPITAL STAY
    Devlin, L. A.
    Radmacher, P.
    Lau, T.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 539 - 539
  • [10] Pharmacogenomic Predictors of Neonatal Abstinence Syndrome: Correlation With Length of Stay
    Kelly, Lauren E.
    Knoppert, Dave
    Koren, Gideon
    [J]. THERAPEUTIC DRUG MONITORING, 2015, 37 (03) : 281 - 282